We are composed of multidisciplinary team of investigators who works to advance the understanding of what constitutes quality mental health for urban families. Read More
Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression
May 20, 2013 - Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.
Mount Sinai Leads Global Program Using Stem Cells to Accelerate Cures for Alzheimer's Disease
March 27, 2013 - Researchers collaborate with the New York Stem Cell Foundation using skin samples and brain imaging to identify causes and cures.
Mary M. McKay, PhD
Icahn School of Medicine
Department of Psychiatry
One Gustave L. Levy Place
New York, NY 10029